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and experimental groups using multistage cluster sampling. The
experimental group received four (4) sessions of 30-minutes nurse
delivered adjunct MI every week for one month, while the control
group received standard health education. MI is a counseling style
thatused speciﬁcquestions todirect behavior changebyexpressing
empathy, developing discrepancy, rolling with resistance and sup-
porting self-efﬁcacy. Adherence was measured using Medication
Adherence Self-Efﬁcacy Scale and Sputum AFB microscopy before
and 2 weeks after the intervention. A panel of experts reviewed
the questionnaire to ensure validity, and the instrument to internal
consistency.
Results: Knowledge about the disease and its treatment com-
bined with motivation can increase self-efﬁcacy to treatment
adherence (Ngamvitroj, 2007). MI as adjunct to health education
can increase treatment adherence (Riekart, 2011). Consequently, a
rapid decrease in the number of M. tuberculosis in sputum. More-
over, studies have shown that MI has signiﬁcant psychological
(75%) and physiological (72%) effect to diseases (Rubak, 2005).
Conclusion: Motivational Interviewing delivered by the nurse
as an adjunct to the standard health education is effective in
enhancing treatment adherence of PTB patients in the health cen-
ter.
http://dx.doi.org/10.1016/j.ijid.2016.02.850
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The referral pathway of presumptive drug
resistant tuberculosis in the urban poor areas of
Metro Manila, Philippines
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Research Institute of Tuberculosis/Japan Anti
Tuberculosis Association, Philippines (RIT/JATA),
Manila City, Philippines
Background: The National Tuberculosis Control Program (NTP)
guidelines emphasize that all presumptive Drug Resistant Tuber-
culosis (DRTB)with history of previous tuberculosis (TB) treatment
and with Multi-Drug Resistant Tuberculosis (MDRTB) contacts
should be screened for MDR. Due to lack of tools to identify the
referral outcome of presumptive DRTB, the RJPI developed an
MDRTB Presumptive Masterlist to account referrals from health
center toMDR treatment center. The study aims tounderstand gaps
in the referral pathway experienced by Local Government Units
(LGUs) and Non-Government Organizations (NGOs) from initial
consultation until initiation of treatment.
Methods & Materials: A retrospective descriptive study of
patients’ data registered onMDRTBPresumptiveMasterlist of eigh-
teen Directly Observed Treatment Short-Course (DOTS) facilities in
District 1 Tondo, Manila and Payatas, Quezon City from October
2012 to September 2013, were reviewed and analyzed using
structured questionnaire. Unpaired t-test used in comparing the
turnaround time between LGUs and NGOs including time between
Direct Sputum Smear Microscopy (DSSM) results presented to
patient and referred toMDR treatment center. A p-value <0.05was
considered statistically signiﬁcant. All analysis performed using
EZR with graphical user interface for R.
Results: A total of 378 Presumptive DRTB was identiﬁed and
listed in the masterlist. Among them, 97% (368/378) referred
and 90% (333/368) screened at MDR Treatemnt center. Among
screened, 85% (283/333) completed the process of MDR screening
and provided with an appropriate treatment based on NTP guide-
lines. 9.5% (35/368) were not screened mainly due to lost to follow
up. The duration of time between sample collected and examined
at laboratory of NGOs was signiﬁcantly longer than LGUs (n=283;
p<0.001). The time duration between the release of DSSM results
and presentation of patient at NGOs was signiﬁcantly shorter than
LGUs (p=0.009).
Conclusion: Development of MDRTB Presumptive Masterlist
has facilitated tracking of patients due for diagnosis and treatment.
Referral system between health center and MDR treatment cen-
ters should be strengthened for proper patient endorsement and
provided with an appropriate action. The NGOs should lessen diag-
nosis delays and LGUs should follow up patient for early start of TB
treatment.
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Predictors, outcome, proﬁle of anti-tubercular
drug induced hepatitis – A prospective nested
case - control study in a South Indian tertiary
hospital
S.S.R. Mani ∗, M. Krishna, R. Iyyadurai, J.H. Prasad,
S. Jasmine, S.G. Hansdak, S. Danda, A. Zachariah
Christian Medical College, Vellore, Vellore, India
Background: Tuberculosis (TB) remains a major global health
problem . The ﬁrst line anti-tubercular drugs are hepatotoxic.
Despite adequate knowledge, we are still unable to predict anti-
tubercular drug induced liver injury (DILI) before initiation of
treatment.
Methods & Materials: This case-control study was nested in
a cohort of patients from Christian Medical College, Vellore who
were newly diagnosed to have tuberculosis and started on treat-
ment. It was carried out from April 2013 to May 2014. All patients
who present with suspected ATT related hepatotoxicity were also
enrolled in the study. All patients on treatment were clinically
assessed for symptoms of hepatitis at every visit until completion
of treatment. The risk factors for ATT induced hepatitiswere identi-
ﬁed by bivariate analysis and logistic regression analysis with odds
ratio and 95% conﬁdence interval.
Results: A total of 393 patientswere eligible for our studywhich
included 5 patients presenting with DILI. Patients on DOTS reg-
imen had lower rates of HIV infection and disseminated disease
but had greater under nutrition when compared with patients on
daily regimen. 43 patients out of 393 patients developed DILI. The
incidence of anti-tubercular drug induced liver injury was 9.7%
(95% C.I 7-13.2%) with lower incidence among patients on DOTS
regimen (14% Vs 3.5%). HIV infection, daily regimen, disseminated
disease, hypoalbuminemia and chronic liver diseasewere indepen-
dent risk factors for development of DILI. A prediction score of >5
based on the above risk factors will predict DILI with a sensitivity
and speciﬁcity of 74% and 67% respectively. All cause mortality in
